BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 23, 2007
View Archived Issues
PharmAthene Gaining Listing, Cash Through Reverse Merger
PharmAthene Inc. is gaining a public listing and up to $70 million in cash through a planned merger with Healthcare Acquisition Corp., a deal coming months after another proposed merged by PharmAthene fell through. (BioWorld Today)
Read More
Analyst: Roche's EPO Drug Near Match With Aranesp
Read More
Two Toxins Make For Vicious Cycle In Common Staph Strain
Read More
Chinese Firm 3SBIO Seeking Nasdaq Listing, $124M In IPO
Read More
Bionovo Raises $15.7M Privately For Cancer, Women's Health
Read More
Other News To Note
Read More
Clinic Roundup
Read More
U.S. Patent Disclosures
Read More